top of page

35+ YEARS IN MEDICAL DEVICE | PHARMACEUTICAL | BIOTECHNOLOGY | DIAGNOSTICS

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...

Executive Spotlights

Lesson’s Learned from Building out the Commercial Organization

SK Life Science breaks through Covid barriers to bring epilepsy drug to market

Lutronic’s Focus on Change during the Pandemic

From Big Pharma to Startup: What are the Challenges?

The View from Olympus: How This MedTech Leader Approached the Pandemic

DENTALEZ COO Heather Trombley on Reinvigorating the Company

Seqirus Exec on Vaccine Differentiation

Zimmer Biomet VP on Covering the Territory

How Teleflex Grew its Market Value 4x in 6 Years

Admedus COO David St. Denis on Courage, Commitment and Conversation

Search

Edgewise Sells Sevasemten Program in Up to $2.65B Deal to Refocus on Cardiovascular Pipeline

4 days ago
1 min read

Boulder, CO, June 1, 2026 (PR Newswire) -- Edgewise Therapeutics has agreed to divest its Sevasemten asset in a transaction valued at up to $2.65 billion. The deal is designed to strengthen the company’s financial position and streamline its strategic focus on cardiovascular drug development. Following the sale, Edgewise plans to concentrate resources on advancing its heart-related therapeutic pipeline.

Read full article here.

Recent Posts

Apogee Secures $1.3B Blackstone Life Sciences Partnership to Advance Late-Stage Immunology Drug Development

San Francisco, CA and Boston, MA, May 27, 2026 (Globe Newswire) -- Apogee Therapeutics has entered a strategic financing collaboration with Blackstone Life Sciences valued at $1.3 billion. The agree

NOWDiagnostics Names Lisa Nibauer as CEO to Drive Innovation and Transformation Strategy

Springdale, AR, May 28, 2026 (PR Newswire) -- NOWDiagnostics has appointed Lisa Nibauer as its new chief executive officer. The leadership change is intended to guide the company’s next phase of inn

NewLimit Raises $435M Financing Round Led by Founders Fund

South San Francisco, CA, June 2, 2026 (NewLimit) -- NewLimit has secured $435 million in funding in a round led by Founders Fund to accelerate development of its longevity-focused platform. The capi

Comments

Life Science Headlines

Apogee Secures $1.3B Blackstone Life Sciences Partnership to Advance Late-Stage Immunology Drug Development

NOWDiagnostics Names Lisa Nibauer as CEO to Drive Innovation and Transformation Strategy

NewLimit Raises $435M Financing Round Led by Founders Fund

West Names Michel Lagarde as CEO to Lead Next Phase of Company Growth

Edgewise Sells Sevasemten Program in Up to $2.65B Deal to Refocus on Cardiovascular Pipeline

Create Medicines Raises $122M Series B to Advance In Vivo CAR Therapies

BD Appoints Peter Menziuso as EVP and President of BD Interventional

Quince Announces OrphAI Acquisition and Up to $187M Private Placement to Advance Pulmonary Pipeline

LifeScan Appoints Jonathan Salkin as CEO Amid Leadership Transition

Biogen Completes $5.3B Acquisition of Apellis to Expand Rare Disease Portfolio

bottom of page